Theratechnologies (TSE:TH) Stock Price Passes Below 50 Day Moving Average of $1.95

Shares of Theratechnologies Inc. (TSE:THGet Free Report) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$1.95 and traded as low as C$1.79. Theratechnologies shares last traded at C$1.85, with a volume of 5,600 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Cantor Fitzgerald restated an “overweight” rating on shares of Theratechnologies in a research note on Friday, January 12th.

Get Our Latest Report on TH

Theratechnologies Stock Up 2.2 %

The firm has a market capitalization of C$85.06 million, a PE ratio of -1.49, a P/E/G ratio of -8.50 and a beta of 1.73. The firm’s 50 day moving average price is C$1.95 and its two-hundred day moving average price is C$2.08. The company has a quick ratio of 0.64, a current ratio of 1.34 and a debt-to-equity ratio of 562.07.

Theratechnologies (TSE:THGet Free Report) last announced its earnings results on Wednesday, February 21st. The company reported C($0.11) earnings per share for the quarter. The firm had revenue of C$31.93 million during the quarter. Theratechnologies had a negative net margin of 29.30% and a negative return on equity of 1,116.86%. As a group, research analysts forecast that Theratechnologies Inc. will post 0.0367421 EPS for the current fiscal year.

Theratechnologies Company Profile

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

See Also

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.